Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
6
×
life sciences
national blog main
new york blog main
6
×
boston blog main
boston top stories
national top stories
new york top stories
clinical trials
san francisco blog main
san francisco top stories
startups
biotech ipos
boston
fda
investing
biogen
blackstone group
cancer immunotherapy
david goldstein
deals
depression
epilepsy
essential tremor
kiran reddy
major depressive disorder
medicare
national
nonalcoholic steatohepatitis
perimenopausal depression
praxis precision medicines
san diego blog main
san diego top stories
steven petrou
89bio
abbvie
acute myeloid leukemia
adrian krainer
alexion pharmaceuticals
aligos therapeutics
What
research
6
×
new
biotech
drugs
medicines
aims
based
ipos
praxis
precision
raised
startup
week
adds
advance
alzheimer’s
annual
approach
arrival
assessed
attention
backed
bio
biolinq
biosensor
biotechs
called
cause
central
ceo
cns
communities
companies
conference
days
debuts
developing
diabetes
disorder
drug
Language
unset
Current search:
research
×
biotech
×
" new york blog main "
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
Biolinq Adds $4.75M to Advance Glucose Monitoring Biosensor Patch
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More